<DOC>
	<DOCNO>NCT02724592</DOCNO>
	<brief_summary>Objectives : Occlusal surface erupt permanent molar highly prone caries . Self-assembling peptide ( P11-4 ) prove enhance biomimetic mineralization early carious lesion . Aim study evaluate safety , clinical applicability effect use P11-4 ( Curodont™ Repair ) non-invasive treatment early occlusal lesion . Methods : 70 patient active early occlusal lesion ( ICDAS-II:1-3 ) first second permanent molar eruption allocate randomize , control , single blind study test ( Curodont™ Repair+Duraphat® ) control ( Duraphat® ) group .</brief_summary>
	<brief_title>Self Assembling Peptide P11-4 Patients With Early Occlusal Carious Lesions</brief_title>
	<detailed_description>Objectives : Occlusal surface erupt permanent molar high prone caries . Self-assembling peptide ( P11-4 ) prove enhance biomimetic mineralization early carious lesion . Aim study evaluate safety , clinical applicability effect use P11-4 ( Curodont™ Repair ) non-invasive treatment early occlusal lesion . Methods : 70 patient active early occlusal lesion ( ICDAS-II:1-3 ) first second permanent molar eruption allocate randomize , control , single blind study test ( Curodont™ Repair+Duraphat® ) control ( Duraphat® ) group . Safety applicability evaluate use dentist's/patient 's questionnaire adverse event , difficulty application satisfaction procedure . Lesions assess baseline recall 3 6 month regard caries activity , clinical status ( ICDAS-II ) Diagnodent® . The Visual Analog Scale ( VAS ) regression lesion size addition Global Impression Change Questionnaire also assess . At every recall , fluoride varnish apply lesion patient receive oral health instruction .</detailed_description>
	<mesh_term>Dental Caries</mesh_term>
	<mesh_term>Sodium fluoride topical preparation</mesh_term>
	<mesh_term>Sodium Fluoride</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<mesh_term>Fluorides , Topical</mesh_term>
	<mesh_term>Listerine</mesh_term>
	<criteria>Early occlusal carious lesion ( without cavity ) permanent molar `` 6 '' `` 7 '' eruption require invasive treatment Age ≥ 5 year Size form lesion : lesion must fully visible assessable accessible Willing able attend onstudy visit observe good oral hygiene throughout study Written inform consent participation study Evidence tooth erosion Fluoride varnish application &lt; 3 month prior study treatment History head neck illness ( e.g . head/neck cancer ) Any pathology concomitant medication affect salivary flow dry mouth Any metabolic disorder affect bone turnover Concurrent participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>